Company / Free Cash Flow per Share
Vaxcyte, Inc. Free Cash Flow per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
-$4.92
FY2025
5-year range
-$4.92 / -$2.46
FY2021-FY2025
Trend
-26.3%
vs FY2024
Sector context
#176 of 192
Health Care
What the data says
Among 192 Health Care companies, Vaxcyte, Inc. is in the bottom 8% for free cash flow per share. Free Cash Flow per Share has declined for 5 consecutive years, from $-1.62 in FY2020 to $-4.92 in FY2025.
Based on SEC 10-K filings.
-4.92 in FY2025.
Declined from $-3.22 to $-4.92 over the past 2 years.
Health Care sector context is included.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 8% in Health CareTop 92% of 192This company -$4.92 Sector average -$19.84
▼
+75.2% above sector average
Key checks
Key Insights
- Vaxcyte, Inc.'s free cash flow per share has declined for 5 consecutive years.
- In FY2025, free cash flow per share decreased 26.3% year-over-year.
- Ranks #176 out of 192 companies in the Health Care sector.
- Peak free cash flow per share was recorded in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 2.94 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$4.92 | -26.3% |
| FY2024 | -$3.89 | -20.9% |
| FY2023 | -$3.22 | -18.4% |
| FY2022 | -$2.72 | -10.4% |
| FY2021 | -$2.46 | -52.4% |
| FY2020 | -$1.62 | +87.3% |
| FY2019 | -$12.74 | -43.4% |
| FY2018 | -$8.88 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026